Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 502.50
+0.20 (0.04%)
Jan 7, 2026, 11:50 AM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 192.16 billion as of January 6, 2026. Its market cap has decreased by -40.36% in one year.
Market Cap
192.16B
Enterprise Value
194.03B
Revenue
12.11B
Ranking
n/a
PE Ratio
73.02
Stock Price
502.50
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 192.16B, an increase of 570,033.44%. That is a compound annual growth rate of 340.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 196.33B | -2.91% |
| Dec 31, 2025 | 202.22B | -30.24% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.76T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 927.70B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |